Sensor to search for artery hardening compounds in blood
A water-soluble zinc-based fluorescent sensor to detect pyrophosphate in blood has been developed by scientists from China. Pyrophosphate plays an important role in metabolic processes in the body but a lack of the compound can lead to Mönckeberg’s arteriosclerosis – calcium deposits in arteries. Too much pyrophosphate causes calcium pyrophosphate deposition disease, where calcium pyrophosphate dihydrate crystals accumulate in connective tissues.
Zhilin Wang from Nanjing University and colleagues made the sensor by binding zinc to a water-soluble naphthalene functionalised tetraazamacrocyle. The resulting compound coordinates to pyrophosphate, forming a complex. They measured the fluorescence of the macrocycle in a neutral buffer solution, when zinc was added and finally when the resulting compound came into contact with pyrophosphate and found that the fluorescence intensities increased each time. The team then tested the sensor in blood serum and found that it performed as well as it had in the buffer.
Current sensors respond to pyrophosphate by changing the fluorescence intensity, which can be disturbed by the environment, says Wang. Ratiometric fluorescence sensors work by calculating the ratio of the fluorescence intensities at two different wavelengths, which is not affected by environmental factors. In the future, Wang hopes to test the sensor in vivo, in particular for toxicity.
Original publication: J Wen, Z Geng, Y Yin, Z Zhang and Z Wang, Dalton Trans., 2011.
Most read news
Organizations
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Potent, puzzling and (now less) toxic: How antifungal drug works
Merck’s new spin-off to focus on infertility treatment
Rapid imaging of granular matter
Millipore Corporation's re-branding underscores expanded capabilities and partnership with customers - Millipore Foundation awards $500,000 research gift to the Harvard Stem Cell Institute
Molecular motion in tire rubber - Tyre components observed with incredible time resolution
University of Leicester researchers discover new fluorescent silicon nanoparticles - Research may ultimately track the uptake of drugs by the body's cells
Bio-Techne to acquire Quad Technologies
BÜCHI acquires NIR-Online
Opto-electronic nose sniffs out toxic gases
ORNL scientists help explain graphene mystery
Altmann Analytik acquires lab supplier Dinkelberg analytics